SHE:300289 Revenue

Beijing Leadman Biochemistry had revenue of 91.76M CNY in the quarter ending September 30, 2025, a decrease of -1.83%. This brings the company's revenue in the last twelve months to 340.65M, down -15.52% year-over-year. In the year 2024, Beijing Leadman Biochemistry had annual revenue of 370.23M, down -19.79%.

Revenue (ttm)

340.65M

Revenue Growth

-15.52%

P/S Ratio

10.97

Revenue / Employee

727.89K

Employees

427

Market Cap

3.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	370.23M	-91.33M	-19.79%
Dec 31, 2023	461.55M	-244.42M	-34.62%
Jan 1, 2023	705.98M	141.92M	25.16%
Jan 1, 2022	564.06M	92.55M	19.63%
Dec 31, 2020	471.51M	-43.63M	-8.47%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chison Medical Technologies	447.35M
Ningbo David Medical Device	516.76M
Shanghai ZJ Bio-Tech	124.91M
Dirui Industrial	511.11M
Wuhan Easy Diagnosis Biomedicine	351.25M
Guangdong Biolight Meditech	1.05B
Beijing Succeeder Technology	263.67M
Getein Biotech	1.04B

Revenue Rankings